Nylim US LG Ca R&D LD ETF-UiLRNDETF
13F holders, Q1 2026 (March 31)5holders
2new positions
2sold out
$37.18avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were New York Life Investment Management LLC ($201.5M), GTS Securities LLC ($831K) and Goldman Sachs Group Inc. ($257K).
- Company
- Nylim US LG Ca R&D LD ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q1 2026)
- CUSIP
- 45409B263
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $257K |
| Exits | 2 | $298K |
All 13F filers, Q4 2025 → Q1 2026: 3,830,672 shares bought and 7,306 shares sold, net +3,823,366 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| New York Life Investment Management LLC | 1.70% | Add +237.7% | 5,419,401 | $201.5M |
| GTS Securities LLC | 0.03% | Add +69.4% | 22,354 | $831K |
| Goldman Sachs Group Inc. | 0.00% | New | 6,925 | $257K |
| Sankala Group LLC | 0.02% | Reduce -1.2% | 570 | $21K |
| Morgan Stanley | 0.00% | New | 1 | $41 |
"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.